Omeros: Why The Novo Nordisk Deal Is More Important Than FDA Approval (Rating Upgrade)

Omeros transitions from a distressed microcap to a small-cap following a transformative Novo Nordisk deal and FDA approval of ...
The American BazaarOpinion

Healthcare year in review 2025: Key trends, challenges and shifts

Healthcare in 2025 saw rapid innovation, rising costs, ACA subsidy expiration, AI adoption, consolidation, and affordability ...

60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State

Further validates continuation of the B-FREE Study to evaluate the efficacy and safety of ARAKODA® (tafenoquine ) for treatment of chronic ...

Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (mAb) Designed for Seasonal Prevention of Lyme Disease (TNX-4800)

Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive field studyExpect to ...
FMIBlog

Global Sodium 3-Nitrobenzenesulfonate Market Set to Grow from USD 8.2 Million in 2025 to USD 11.0 Million by 2035 as Established and Emerging Players Accelerate In…

The global sodium 3-nitrobenzenesulfonate market is poised for consistent and sustainable growth, with projected expansion ...
FMIBlog

Oil-in-Water Anionic Emulsifier Market Poised for Steady Expansion on the Back of Food, Personal Care, and Industrial Demand

With processed and convenience food consumption rising across Europe, Asia, and North America, demand for oil-in-water ...